Genetic HIF-1 and/or HIF-2 deletion accelerates leukemogenesis5,6, suggesting a tumor-suppressor function of HIFs in AML; however, the functional significance of activation of the HIF system on AML has not previously been explored. The gene discussed is HIF1A; the disease is neoplasm.